Contract analysis

I. EXECUTIVE SUMMARY The purpose of this memorandum is to assess whether Marlowe Asset Management Photonics Inc.'s ("VPI") current and planned gallium-nitride high-electron-mobility transistor ("GaN HEMT") and millimeter-wave ("mmWave") power amplifier product lines create infringement exposure with respect to third-party patent rights, and to identify any freedom-to-operate ("FTO") risks material to Halcyon Semicond

1. No current infringement exposure. We have identified no current infringement exposure with respect to VPI's existing commercial and defense product lines as presently manufactured and sold. VPI's products, as currently configured and produced at VPI's Albuquerque, New Mexico fabrication facility, do not practice any claim of any identified third-party U.S. patent.

2. Three patent families warrant ongoing monitoring. We have identified three third-party patent families that warrant ongoing monitoring due to their adjacency to VPI's technology. These families are held by Apex Microelectronics Corp. (GaN HEMT diamond thermal management), Wideband Innovations LLC (mmWave broadband matching networks), and Cerulean Semiconductor Technologies Ltd. (GaN epitaxial buffer layer structur

3. Transaction impact. We do not recommend any adjustment to the transaction valuation or any specific indemnification carve-outs on account of FTO risk. The identified risks are manageable through a routine post-closing patent watch program and periodic re-assessment, the costs of which are modest relative to the transaction value.

4. Post-closing recommendations. We recommend that VPI implement an ongoing patent watch program following the closing of the transaction to monitor the three identified patent families and any related continuation or divisional applications. We also recommend the preparation of formal design-around memoranda and periodic FTO re-assessments at twelve-month intervals or upon any material change in VPI product designs.

5. Defensive portfolio leverage. VPI's own portfolio of forty-seven (47) granted and twelve (12) pending U.S. patents — analyzed separately in Omar Siddiqui's VPI Patent Portfolio Summary dated August 22, 2023 — provides a significant degree of defensive cross-licensing leverage in the event any third-party dispute materializes. This portfolio, combined with the government contractor defense available for VPI's subst

II. BACKGROUND AND CONTEXT A. Transaction Overview Halcyon Semiconductor Aktiengesellschaft ("HSAG"), a publicly traded German semiconductor company listed on the Frankfurt Stock Exchange (XETRA: HLC), with its registered office and principal place of business at Industriestraße 44, 01099 Dresden, Saxony, Germany, is acquiring one hundred percent (100%) of the outstanding equity interests of Marlowe Asset Management

III. VPI PRODUCT LINE BREAKDOWN FOR FTO PURPOSES To ensure a thorough and well-organized FTO analysis, we have structured our review around VPI's three principal technology areas. Each is described below with sufficient technical detail to support the claim-comparison analysis presented in Section IV and the claim charts set forth in Appendix 2. A. GaN HEMT Discrete Devices and Monolithic Microwave Integrated Circuit

IV. THIRD-PARTY PATENT FAMILIES WARRANTING MONITORING Of the approximately 340 U.S. patents and published applications reviewed in the landscape search (described in detail in Appendix 3), we identified three third-party patent families that warrant ongoing monitoring due to their proximity to VPI's technology. We emphasize at the outset that none of these patent families currently presents an actionable infringement

V. OTHER PATENTS REVIEWED AND CLEARED A. Summary of Broader Search Results The patent landscape search described in Section II.D resulted in the identification and initial review of approximately 340 U.S. patents and published applications with potential relevance to VPI's product lines and manufacturing processes. A complete listing of all patents and applications reviewed, including assignee, title, priority date,

VI. IMPACT OF GOVERNMENT CONTRACTOR STATUS ON FTO RISK As noted in Section II.C, the government contractor defense under 28 U.S.C. § 1498 provides significant protection for a substantial portion of VPI's product output. This section elaborates on the scope and significance of that protection. Statutory Framework. Under 28 U.S.C. § 1498(a), whenever an invention described in and covered by a U.S. patent is used or ma

VII. IMPLICATIONS FOR NSA AND TECHNOLOGY CONTROL PLAN The CFIUS review process and the anticipated NSA and Technology Control Plan impose certain restrictions on HSAG's access to and use of VPI's intellectual property. While the detailed analysis of these restrictions is set forth in Peggy Ashworth's NSA/TCP negotiation memoranda and in the IP Transfer Restriction Analysis memo, we note here the FTO-related implicati

VIII. RECOMMENDATIONS Based on the analysis presented in this memorandum, we make the following recommendations. A. No Current Litigation or Licensing Action Required We conclude that VPI's current products and manufacturing processes do not infring